These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11123452)

  • 1. Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.
    Smith EB; Stein LF; Fivenson DP; Atillasoy ES
    Int J Dermatol; 2000 Nov; 39(11):861-4. PubMed ID: 11123452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 2001 Mar; 91(3):127-31. PubMed ID: 11266494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial.
    Jennings MB; Pollak R; Harkless LB; Kianifard F; Tavakkol A
    J Am Podiatr Med Assoc; 2006; 96(6):465-73. PubMed ID: 17114599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
    Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
    Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of oral terbinafine for toenail onychomycosis.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 1997 Dec; 87(12):565-70. PubMed ID: 9425805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
    Drake LA; Shear NH; Arlette JP; Cloutier R; Danby FW; Elewski BE; Garnis-Jones S; Giroux JM; Gratton D; Gulliver W; Hull P; Jones HE; Journet M; Krol AL; Leyden JJ; Maddin SC; Ross JB; Savin RC; Scher RK; Sibbald GR; Tawfik NH; Zaias N; Tolpin M; Evans S; Birnbaum JE
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):740-5. PubMed ID: 9366820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine.
    Watson AB; Marley JE; Ellis DH; Williams TG
    Australas J Dermatol; 1998 Feb; 39(1):29-30. PubMed ID: 9529685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine in onychomycosis of the toenail: a novel treatment protocol.
    Watson A; Marley J; Ellis D; Williams T
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):775-9. PubMed ID: 7593777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
    Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
    J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.